|
[1]
|
Zhang, R., Xie, Q., Lu, X., Fan, R. and Tong, N. (2024) Research Advances in the Anti-Inflammatory Effects of SGLT Inhibitors in Type 2 Diabetes Mellitus. Diabetology & Metabolic Syndrome, 16, Article No. 99. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Parsons, N., Annamalai, B., Obert, E., Schnabolk, G., Tomlinson, S. and Rohrer, B. (2019) Inhibition of the Alternative Complement Pathway Accelerates Repair Processes in the Murine Model of Choroidal Neovascularization. Molecular Immunology, 108, 8-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Ohashi, T. and Erickson, H.P. (1998) Oligomeric Structure and Tissue Distribution of Ficolins from Mouse, Pig and Human. Archives of Biochemistry and Biophysics, 360, 223-232. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Yokota, Y., Arai, T. and Kawasaki, T. (1995) Oligomeric Structures Required for Complement Activation of Serum Mannan-Binding Proteins. Journal of Biochemistry, 117, 414-419. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Yae, Y., Inaba, S., Sato, H., Okochi, K., Tokunaga, F. and Iwanaga, S. (1991) Isolation and Characterization of a Thermolabile β-2 Macroglycoprotein (‘Thermolabile Substance’ or ‘Hakata Antigen’) Detected by Precipitating (Auto) Antibody in Sera of Patients with Systemic Lupus Erythematosus. Biochimica et Biophysica Acta—Protein Structure and Molecular Enzymology, 1078, 369-376. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Garlatti, V., Martin, L., Lacroix, M., Gout, E., Arlaud, G.J., Thielens, N.M., et al. (2010) Structural Insights into the Recognition Properties of Human Ficolins. Journal of Innate Immunity, 2, 17-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kilpatrick, D.C. and Chalmers, J.D. (2012) Human L-Ficolin (Ficolin-2) and Its Clinical Significance. Journal of Biomedicine and Biotechnology, 2012, 1-10. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Endo, Y., Sato, Y., Matsushita, M. and Fujita, T. (1996) Cloning and Characterization of the Human Lectin P35 Gene and Its Related Gene. Genomics, 36, 515-521. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Liu, Y., Endo, Y., Homma, S., Kanno, K., Yaginuma, H. and Fujita, T. (2005) Ficolin A and Ficolin B Are Expressed in Distinct Ontogenic Patterns and Cell Types in the Mouse. Molecular Immunology, 42, 1265-1273. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Garred, P., Honoré, C., Ma, Y.J., Rørvig, S., Cowland, J., Borregaard, N., et al. (2010) The Genetics of Ficolins. Journal of Innate Immunity, 2, 3-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Ohashi, T. and Erickson, H.P. (1997) Two Oligomeric Forms of Plasma Ficolin Have Differential Lectin Activity. Journal of Biological Chemistry, 272, 14220-14226. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Girija, U.V., Mitchell, D.A., Roscher, S. and Wallis, R. (2011) Carbohydrate Recognition and Complement Activation by Rat Ficolin-B. European Journal of Immunology, 41, 214-223. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kakinuma, Y., Endo, Y., Takahashi, M., Nakata, M., Matsushita, M., Takenoshita, S., et al. (2003) Molecular Cloning and Characterization of Novel Ficolins from Xenopus laevis. Immunogenetics, 55, 29-37. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Matsushita, M. and Fujita, T. (1992) Activation of the Classical Complement Pathway by Mannose-Binding Protein in Association with a Novel C1s-Like Serine Protease. The Journal of Experimental Medicine, 176, 1497-1502. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Takahashi, M., Iwaki, D., Kanno, K., Ishida, Y., Xiong, J., Matsushita, M., et al. (2008) Mannose-Binding Lectin (MBL)-Associated Serine Protease (MASP)-1 Contributes to Activation of the Lectin Complement Pathway. The Journal of Immunology, 180, 6132-6138. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Takahashi, M., Ishida, Y., Iwaki, D., Kanno, K., Suzuki, T., Endo, Y., et al. (2010) Essential Role of Mannose-Binding Lectin-Associated Serine Protease-1 in Activation of the Complement Factor D. Journal of Experimental Medicine, 207, 29-37. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Matsushita, M., Endo, Y. and Fujita, T. (2013) Structural and Functional Overview of the Lectin Complement Pathway: Its Molecular Basis and Physiological Implication. Archivum Immunologiae et Therapiae Experimentalis, 61, 273-283. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Nauta, A.J., Bottazzi, B., Mantovani, A., Salvatori, G., Kishore, U., Schwaeble, W.J., et al. (2003) Biochemical and Functional Characterization of the Interaction between Pentraxin 3 and C1q. European Journal of Immunology, 33, 465-473. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Wu, Q., Cao, F., Tao, J., Li, X., Zheng, S.G. and Pan, H. (2020) Pentraxin 3: A Promising Therapeutic Target for Autoimmune Diseases. Autoimmunity Reviews, 19, Article 102584. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Gout, E., Moriscot, C., Doni, A., Dumestre-Pérard, C., Lacroix, M., Pérard, J., et al. (2011) M-Ficolin Interacts with the Long Pentraxin PTX3: A Novel Case of Cross-Talk between Soluble Pattern-Recognition Molecules. The Journal of Immunology, 186, 5815-5822. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Le, Y., Lee, S.H., Kon, O.L. and Lu, J. (1998) Human l-Ficolin: Plasma Levels, Sugar Specificity, and Assignment of Its Lectin Activity to the Fibrinogen-Like (FBG) Domain. FEBS Letters, 425, 367-370. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Liu, Y., Endo, Y., Iwaki, D., Nakata, M., Matsushita, M., Wada, I., et al. (2005) Human M-Ficolin Is a Secretory Protein That Activates the Lectin Complement Pathway. The Journal of Immunology, 175, 3150-3156. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Kwon, S., Kim, M., Kim, D., Lee, K., Choi, S., Park, J., et al. (2007) Identification of a Functionally Relevant Signal Peptide of Mouse Ficolin A. BMB Reports, 40, 532-538. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Kuraya, M., Ming, Z., Liu, X., Matsushita, M. and Fujita, T. (2005) Specific Binding of L-Ficolin and H-Ficolin to Apoptotic Cells Leads to Complement Activation. Immunobiology, 209, 689-697. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Brinkmann, C.R., Jensen, L., Dagnæs-Hansen, F., Holm, I.E., Endo, Y., Fujita, T., et al. (2013) Mitochondria and the Lectin Pathway of Complement. Journal of Biological Chemistry, 288, 8016-8027. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
杨一菲. Ficolin-A/2在炎症性肠病中的作用及相关机制研究[D]: [博士学位论文]. 武汉: 武汉大学, 2017.
|
|
[27]
|
丁荃荃. Ficolin-2/A在体内发挥抗肿瘤效应及其激活免疫细胞机制的研究[D]: [博士学位论文]. 武汉: 武汉大学, 2017.
|
|
[28]
|
O’Brien, K.L., Wolfson, L.J., Watt, J.P., Henkle, E., Deloria-Knoll, M., McCall, N., et al. (2009) Burden of Disease Caused by Streptococcus Pneumoniae in Children Younger than 5 Years: Global Estimates. The Lancet, 374, 893-902. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Gisch, N., Kohler, T., Ulmer, A.J., Müthing, J., Pribyl, T., Fischer, K., et al. (2013) Structural Reevaluation of Streptococcus Pneumoniae Lipoteichoic Acid and New Insights into Its Immunostimulatory Potency. Journal of Biological Chemistry, 288, 15654-15667. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Gehre, F., Spisek, R., Kharat, A.S., Matthews, P., Kukreja, A., Anthony, R.M., et al. (2009) Role of Teichoic Acid Choline Moieties in the Virulence of Streptococcus pneumoniae. Infection and Immunity, 77, 2824-2831. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Kharat, A.S. and Tomasz, A. (2006) Drastic Reduction in the Virulence of Streptococcus pneumoniae Expressing Type 2 Capsular Polysaccharide but Lacking Choline Residues in the Cell Wall. Molecular Microbiology, 60, 93-107. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Endo, Y., Takahashi, M., Iwaki, D., Ishida, Y., Nakazawa, N., Kodama, T., et al. (2012) Mice Deficient in Ficolin, a Lectin Complement Pathway Recognition Molecule, Are Susceptible to Streptococcus pneumoniae Infection. The Journal of Immunology, 189, 5860-5866. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Vassal-Stermann, E., Lacroix, M., Gout, E., Laffly, E., Pedersen, C.M., Martin, L., et al. (2014) Human L-Ficolin Recognizes Phosphocholine Moieties of Pneumococcal Teichoic Acid. The Journal of Immunology, 193, 5699-5708. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Wu, X., Yao, D., Bao, L., Liu, D., Xu, X., An, Y., et al. (2020) Ficolin a Derived from Local Macrophages and Neutrophils Protects against Lipopolysaccharide-Induced Acute Lung Injury by Activating Complement. Immunology & Cell Biology, 98, 595-606. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Wu, X., Xuan, W., Yang, X., Liu, W., Zhang, H., Jiang, G., et al. (2023) Ficolin a Knockout Alleviates Sepsis-Induced Severe Lung Injury in Mice by Restoring Gut Akkermansia to Inhibit S100A4/STAT3 Pathway. International Immunopharmacology, 121, Article 110548. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Huang, L., Tan, X., Xuan, W., Luo, Q., Xie, L., Xi, Y., et al. (2024) Ficolin-A/2 Aggravates Severe Lung Injury through Neutrophil Extracellular Traps Mediated by Gasdermin D-Induced Pyroptosis. The American Journal of Pathology, 194, 989-1006. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Giraudi, P.J., Salvoza, N., Bonazza, D., Saitta, C., Lombardo, D., Casagranda, B., et al. (2022) Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 23, Article 2813. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Herrscher, C., Roingeard, P. and Blanchard, E. (2020) Hepatitis B Virus Entry into Cells. Cells, 9, Article 1486. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Catanese, M.T., Ansuini, H., Graziani, R., Huby, T., Moreau, M., Ball, J.K., et al. (2010) Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants. Journal of Virology, 84, 34-43. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Evans, M.J., von Hahn, T., Tscherne, D.M., Syder, A.J., Panis, M., Wölk, B., et al. (2007) Claudin-1 Is a Hepatitis C Virus Co-Receptor Required for a Late Step in Entry. Nature, 446, 801-805. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Ploss, A., Evans, M.J., Gaysinskaya, V.A., Panis, M., You, H., de Jong, Y.P., et al. (2009) Human Occludin Is a Hepatitis C Virus Entry Factor Required for Infection of Mouse Cells. Nature, 457, 882-886. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Benedicto, I., Molina-Jiménez, F., Bartosch, B., Cosset, F., Lavillette, D., Prieto, J., et al. (2009) The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection. Journal of Virology, 83, 8012-8020. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Liu, J., Ali, M.A.M., Shi, Y., Zhao, Y., Luo, F., Yu, J., et al. (2009) Specifically Binding of L-Ficolin to N-Glycans of HCV Envelope Glycoproteins E1 and E2 Leads to Complement Activation. Cellular & Molecular Immunology, 6, 235-244. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Hamed, M.R., Brown, R.J.P., Zothner, C., Urbanowicz, R.A., Mason, C.P., Krarup, A., et al. (2014) Recombinant Human L-Ficolin Directly Neutralizes Hepatitis C Virus Entry. Journal of Innate Immunity, 6, 676-684. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Zhao, Y., Ren, Y., Zhang, X., Zhao, P., Tao, W., Zhong, J., et al. (2014) Ficolin-2 Inhibits Hepatitis C Virus Infection, Whereas Apolipoprotein E3 Mediates Viral Immune Escape. The Journal of Immunology, 193, 783-796. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Hu, Y.L., Luo, F.L., Fu, J.L., Chen, T.L., et al. (2013) Early Increased Ficolin-2 Concentrations Are Associated with Severity of Liver Inflammation and Efficacy of Anti-Viral Therapy in Chronic Hepatitis C Patients. Scandinavian Journal of Immunology, 77, 144-150. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Schaffer, T., Schoepfer, A.M. and Seibold, F. (2014) Serum Ficolin-2 Correlates Worse than Fecal Calprotectin and CRP with Endoscopic Crohn’s Disease Activity. Journal of Crohn’s and Colitis, 8, 1125-1132. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Carbone, F., Valente, A., Perego, C., Bertolotto, M., Pane, B., Spinella, G., et al. (2021) Ficolin-2 Serum Levels Predict the Occurrence of Acute Coronary Syndrome in Patients with Severe Carotid Artery Stenosis. Pharmacological Research, 166, Article 105462. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Formanowicz, D., Gutowska, K. and Formanowicz, P. (2018) Theoretical Studies on the Engagement of Interleukin 18 in the Immuno-Inflammatory Processes Underlying Atherosclerosis. International Journal of Molecular Sciences, 19, Article 3476. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Sprong, T., Jack, D.L., Klein, N.J., Turner, M.W., van der Ley, P., Steeghs, L., et al. (2004) Mannose Binding Lectin Enhances Il-1β and IL-10 Induction by Non-Lipopolysaccharide (LPS) Components of Neisseria Meningitidis. Cytokine, 28, 59-66. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Bi, X., Vitali, C. and Cuchel, M. (2015) ABCA1 and Inflammation: From Animal Models to Humans. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 1551-1553. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Tumurkhuu, G., Dagvadorj, J., Porritt, R.A., Crother, T.R., Shimada, K., Tarling, E.J., et al. (2018) Chlamydia Pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis. Cell Metabolism, 28, 432-448.e4. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Yu, X., Jiang, H., Chen, W., Yin, K., Zhao, G., Mo, Z., et al. (2012) Interleukin-18 and Interleukin-12 Together Downregulate ATP-Binding Cassette Transporter A1 Expression through the Interleukin-18R/Nuclear Factor-κB Signaling Pathway in THP-1 Macrophage-Derived Foam Cells. Circulation Journal, 76, 1780-1791. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Khan, R., Rheaume, E. and Tardif, J. (2018) Examining the Role of and Treatment Directed at IL-1β in Atherosclerosis. Current Atherosclerosis Reports, 20, Article No. 53. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Grebe, A., Hoss, F. and Latz, E. (2018) NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circulation Research, 122, 1722-1740. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Elhage, R., Jawien, J., Rudling, M., Ljunggren, H.G., et al. (2003) Reduced Atherosclerosis in Interleukin-18 Deficient Apolipoprotein E-Knockout Mice. Cardiovascular Research, 59, 234-240. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
刘艾婷. 纤维蛋白胶凝素-2通过上调巨噬细胞NLRP3炎症小体活性促进巨噬细胞泡沫化[D]: [硕士学位论文]. 衡阳: 南华大学, 2020.
|
|
[58]
|
Macarie, R.D., Tucureanu, M.M., Ciortan, L., Gan, A., Butoi, E. and Mânduțeanu, I. (2023) Ficolin-2 Amplifies Inflammation in Macrophage-Smooth Muscle Cell Cross-Talk and Increases Monocyte Transmigration by Mechanisms Involving IL-1β and IL-6. Scientific Reports, 13, Article No. 19431. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Fumagalli, S., Perego, C., Zangari, R., De Blasio, D., Oggioni, M., De Nigris, F., et al. (2017) Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques. Frontiers in Immunology, 8, Article 288. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Cheng, Y., Chen, Y., Sun, X., Li, Y., Huang, C., Deng, H., et al. (2014) Identification of Potential Serum Biomarkers for Rheumatoid Arthritis by High-Resolution Quantitative Proteomic Analysis. Inflammation, 37, 1459-1467. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Zhu, L., Li, Z., Dong, X., Wu, H., Cheng, Y., Xia, S., et al. (2024) Ficolin-A Induces Macrophage Polarization to a Novel Pro-Inflammatory Phenotype Distinct from Classical M1. Cell Communication and Signaling, 22, Article No. 271. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Watanabe, H., Saito, R., Asano, T., Sato, S., Iwadate, H., Kobayashi, H., et al. (2012) Serum L-Ficolin Levels in Patients with Systemic Lupus Erythematosus. Modern Rheumatology, 22, 899-902. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Colliard, S., Jourde-Chiche, N., Clavarino, G., Sarrot-Reynauld, F., Gout, E., Deroux, A., et al. (2018) Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients with Active Nephritis. Arthritis Care & Research, 70, 1263-1268. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Nisihara, R.M., Magrini, F., Mocelin, V. and Messias-Reason, I.J. (2013) Deposition of the Lectin Pathway of Complement in Renal Biopsies of Lupus Nephritis Patients. Human Immunology, 74, 907-910. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., et al. (2025) Inflammation in Cancer: Therapeutic Opportunities from New Insights. Molecular Cancer, 24, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Ding, Q., Shen, Y., Li, D., Yang, J., Yu, J., Yin, Z., et al. (2017) Ficolin-2 Triggers Antitumor Effect by Activating Macrophages and CD8+ T Cells. Clinical Immunology, 183, 145-157. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Sica, A. and Mantovani, A. (2012) Macrophage Plasticity and Polarization: In Vivo Veritas. Journal of Clinical Investigation, 122, 787-795. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Larocca, C., Cohen, J.R., Fernando, R.I., Huang, B., Hamilton, D.H. and Palena, C. (2013) An Autocrine Loop between TGF-β1 and the Transcription Factor Brachyury Controls the Transition of Human Carcinoma Cells into a Mesenchymal Phenotype. Molecular Cancer Therapeutics, 12, 1805-1815. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Heldin, C., Vanlandewijck, M. and Moustakas, A. (2012) Regulation of EMT by TGFβ in Cancer. FEBS Letters, 586, 1959-1970. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Padua, D. and Massagué, J. (2009) Roles of TGFβ in Metastasis. Cell Research, 19, 89-102. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Yang, G., Liang, Y., Zheng, T., Song, R., Wang, J., Shi, H., et al. (2016) FCN2 Inhibits Epithelial-Mesenchymal Transition-Induced Metastasis of Hepatocellular Carcinoma via TGF-β/Smad Signaling. Cancer Letters, 378, 80-86. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Liang, J., Pan, Y., Yang, J., Zeng, D. and Li, J. (2025) WNT Signaling in Cancer: Molecular Mechanisms and Potential Therapies. Molecular Biomedicine, 6, Article No. 83. [Google Scholar] [CrossRef]
|